IQVIA Holdings Inc.IQV

Health Care · Health Care Equipment & Services · NYSE · United States · iqvia.com

IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences and healthcare industry. The company combines proprietary data assets, domain expertise, and technology platforms to help biopharmaceutical companies accelerate the development and commercialization of medicines. IQVIA serves clients in over 100 countries through its contract research and real-world evidence capabilities.

Key ratios

Operating cash flow growth

7.7%TTM

2025 -2.3%2024 26.4%2023 -4.9%

EPS growth

16.7%TTM

2025 4.7%2024 2.7%2023 27.5%

FCF / Sales

12.9%TTM

2025 12.6%2024 13.7%2023 10.0%

Net margin

8.1%TTM

2025 8.3%2024 8.9%2023 9.1%

ROA

5.1%TTM

2025 5.1%2024 5.3%2023 5.0%

ROE

22.8%TTM

2025 21.4%2024 22.6%2023 22.9%

Revenue growth

8.2%TTM

2025 5.9%2024 2.8%2023 4.0%

Recent news

IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery 2026-08-04 · GlobeNewswire IQVIA Announces Pricing of Senior Notes 2026-06-05 · BioSpace IQVIA CEO to Speak at Jefferies Global Healthcare Conference 2026 2026-05-26 · BioSpace IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization 2026-05-07 · IQVIA Holdings

Track IQV in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer